Latest / Dayton News Today | 2 Min News | The Daily News Now!
mRNA Vaccines Fight Cancer Recurrence | Dayton News
A groundbreaking new study reveals personalized mRNA vaccines—same tech that fought COVID-19—are now slashing cancer recurrence in melanoma patients when paired with Keytruda. Scientists are adapting this “biological software” to target unique tumor genetics across cancers like bladder and lung, creating custom immune attacks. The combo works by disabling tumor defenses and training T cells to hunt rogue cells—a two-pronged assault. While cost and access remain hurdles, distributed manufacturing could make it affordable within five years. Merck and Moderna are racing toward approval, poised…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.